Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
| Autor: | Garber, Alan J, King, Allen B, Prato, Stefano Del, Sreenan, Seamus, Balci, Mustafa K, Muñoz-Torres, Manuel, Rosenstock, Julio, Endahl, Lars A, Francisco, Ann Marie Ocampo, Hollander, Priscilla |
|---|---|
| Zdroj: | In The Lancet 21-27 April 2012 379(9825):1498-1507 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|